CompletedNCT04182113
This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Indiana University
- Condition
- Schizophrenia
CompletedNCT04787302
This study exists to explore whether the medication CVL-231 could improve care and understanding. Researchers are trying to understand what the medication CVL-231 can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Belgium, United States
- Sponsor
- Cerevel Therapeutics, LLC
- Condition
- Schizophrenia
Not Yet RecruitingNCT05948111
This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Power Life Sciences Inc.
- Condition
- Schizophrenia
CompletedNCT01291511
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- India, Ukraine, United States
- Sponsor
- Vanda Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT04221269
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Butler Hospital
- Condition
- Schizophrenia
CompletedNCT01521026
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT04712734
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanda Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT03671525
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Schizophrenia
CompletedNCT03962348
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- Columbia University
- Condition
- Schizophrenia
CompletedNCT04268303
This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- BioXcel Therapeutics Inc
- Condition
- Schizophrenia
CompletedNCT03617783
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
TerminatedNCT04421456
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Poland, Serbia, Spain, United States
- Sponsor
- Jazz Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT02505477
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of California, Los Angeles
- Condition
- Schizophrenia
CompletedNCT03826563
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 11 Years to 30 Years
- Countries
- United States
- Sponsor
- Children's Hospital of Philadelphia
- Condition
- Schizophrenia
CompletedNCT03397134
This study exists to compare options and see whether the medication MIN-101 offers something meaningfully different. Researchers are trying to understand how people respond to the medication MIN-101 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Bulgaria, Poland, Ukraine, United States
- Sponsor
- Minerva Neurosciences
- Condition
- Schizophrenia
CompletedNCT04922593
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Luye Pharma Group Ltd.
- Condition
- Schizophrenia
CompletedNCT04689867
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Michigan
- Condition
- Schizophrenia
TerminatedNCT01844726
This study exists to explore whether the medication GLYX-13 could improve care and understanding. Researchers are trying to understand whether the medication GLYX-13 can improve attention, thinking, or day-to-day functioning.
Mental healthOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Northwestern University
- Condition
- Mental health
CompletedNCT02131129
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- United States
- Sponsor
- Indiana University
- Condition
- Schizophrenia
CompletedNCT03745820
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Germany, Japan, Spain, United Kingdom, United States
- Sponsor
- Biogen
- Condition
- Schizophrenia
CompletedNCT03270098
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Condition
- Schizophrenia
CompletedNCT04010747
This study exists to see whether the medication Motivational is workable and worth testing more broadly. Researchers are trying to understand what helps the medication Motivational stay useful, realistic, and easier to follow over time.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Boston Medical Center
- Condition
- Schizophrenia
CompletedNCT01606436
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT00635700
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 16 Years to 40 Years
- Countries
- Canada, United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT05601050
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 40 Years
- Countries
- United States
- Sponsor
- Northwell Health
- Condition
- Schizophrenia